
BAC · NYSE
The supplied consensus is Buy among 24 analysts, with a mean target of $63; low and high targets are unavailable, so the target cluster and full spread cannot be established. Other supplied aggregators report a $62.95 average target from 25 analysts, while Public reports 18 Buy ratings and a $61.39 forecast, indicating variation in coverage and methodology. Citigroup is the only named firm with a specific target change in the evidence: it maintained Buy while lowering its target from $66 to $60, but the change’s date is not stated, so it cannot be assigned to this week. No evidence identifies the most bullish analyst or establishes weekly revision direction. The substantive debate is whether NII and deposit strength outweigh rising costs and trading volatility.